ClinicalTrials.govpublic full text
Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
advanced cancer, advanced metastatic cancer (solid tumors), pi3k, mtor, mek, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 857338
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.